Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants

NCT ID: NCT04295395

Last Updated: 2023-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-09

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the brain and renal oxygenation using near infrared spectroscopy in preterm infants with persistent ductus arteriosus

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patent ductus arteriosus (PDA) is common in preterm infants. In the presence of a large PDA, significant systemic to pulmonary shunting occurs, which may result in pulmonary hyperperfusion and systemic hypoperfusion.

The evidence on PDA effect on brain and renal tissue oxygenation, measured by Near Infrared Spectroscopy is still controversial.

This study aims to evaluate the brain and renal oxygenation using near infrared spectroscopy (NONIN SenSmart model X-100) in 3 groups of preterm infants: 1) closed ductus arteriosus, 2) persistent ductus arteriosus, 3) hemodynamicaly significant ductus arteriosus.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pre-Term Persistent Ductus Arteriosus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group1

preterm infant with closed ductus arteriosus, \<32 weeks birth weight \< 1500g, and \> 72 hours of age

NONIN SenSmart model X-100 near- infrared spectrometer

Intervention Type DEVICE

for to measure cerebral (cSO2) and renal (rSO2 ) regional tissue oxygen saturation on the day after echocardiography was done. The sensors were placed on the right/left forehead and the right/left lateral posterior flank

group2

preterm infant with PDA \< 32 weeks, birth weight \< 1500g, and \> 72 hours of age

NONIN SenSmart model X-100 near- infrared spectrometer

Intervention Type DEVICE

for to measure cerebral (cSO2) and renal (rSO2 ) regional tissue oxygen saturation on the day after echocardiography was done. The sensors were placed on the right/left forehead and the right/left lateral posterior flank

group3

preterm infant with hemodynamically significant PDA \< 32 weeks, birth weight \< 1500g, and \> 72 hours of age

NONIN SenSmart model X-100 near- infrared spectrometer

Intervention Type DEVICE

for to measure cerebral (cSO2) and renal (rSO2 ) regional tissue oxygen saturation on the day after echocardiography was done. The sensors were placed on the right/left forehead and the right/left lateral posterior flank

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NONIN SenSmart model X-100 near- infrared spectrometer

for to measure cerebral (cSO2) and renal (rSO2 ) regional tissue oxygen saturation on the day after echocardiography was done. The sensors were placed on the right/left forehead and the right/left lateral posterior flank

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

GE LOGIQ S8 XDclear 2.0 ultrasoud

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* preterm infants with gestation age of \< 32 weeks
* birth weight \< 1500g
* \> 72 hours of age.

Exclusion Criteria

* cardiovascular, renal, cerebral congenital defects,
* confirmed sepsis,
* no parental consent
Minimum Eligible Age

22 Weeks

Maximum Eligible Age

32 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vilnius University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Augustina Jankauskiene, MD

Role: STUDY_DIRECTOR

Vilnius University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vilnius University Santaros Klinikos Neonatology Center

Vilnius, , Lithuania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lithuania

References

Explore related publications, articles, or registry entries linked to this study.

Navikiene J, Virsilas E, Vankeviciene R, Liubsys A, Jankauskiene A. Brain and renal oxygenation measured by NIRS related to patent ductus arteriosus in preterm infants: a prospective observational study. BMC Pediatr. 2021 Dec 9;21(1):559. doi: 10.1186/s12887-021-03036-w.

Reference Type DERIVED
PMID: 34886825 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AIRS-2017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NIRS Monitoring in the NICU and AKI
NCT07222722 RECRUITING NA
Neonatal Brain Oxygenation Study
NCT04439968 ACTIVE_NOT_RECRUITING NA
Investigating Cerebral Oxygenation in the Newborn
NCT05588960 ACTIVE_NOT_RECRUITING